Regenerative Medicine Using Extracellular Vesicles and Nano-particles from Amniotic Fluid to Treat Degenerative Diseases with Dr. George Shapiro Organicell TRANSCRIPT
Download PDFJun 2, 2020
Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients. Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their...
Jun 2, 2020
Dr. George Shapiro, Chief Medical Officer, Organicell describes the regenerative medicine challenges to regenerate tissue and avoid surgery in patients. Organicall is using extracellular vesicles and perinatal derived nano-particles from amniotic fluid taken in the operating room from planned C-section US births. Their...
Cell Therapy and Regenerative Medicine Advances with Dr. Gil Van Bokkelen Athersys TRANSCRIPT
Download PDFMar 10, 2020
Dr. Gil Van Bokkelen, founder and CEO, Athersys a clinical stage biotech company, talks about developing cell therapies and regenerative medicine as alternatives to conventional standards of medical intervention and treatment using their MultiStem cell therapy platform. Gil explains how cell therapies work by providing...
Mar 10, 2020
Dr. Gil Van Bokkelen, founder and CEO, Athersys a clinical stage biotech company, talks about developing cell therapies and regenerative medicine as alternatives to conventional standards of medical intervention and treatment using their MultiStem cell therapy platform. Gil explains how cell therapies work by providing...
Apr 22, 2019
Dr. Jay Venkatesan, CEO, Angion, a clinical stage biopharmaceutical company, discusses the company's work in organ self-repair and their initial focus in the nephrology space. The company's lead candidate ANG-3777 is a small molecule that mimics a protein to stimulate this self-repair and regeneration following injury....